02 JUN 2016 Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma PNI Publications Share: Previous Precision Cancer Care in 2016 Next Tumor-killing virus nearly doubles survival time of brain cancer patients in a small trial
02 JUN 2016 Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma PNI Publications Share: Previous Precision Cancer Care in 2016 Next Tumor-killing virus nearly doubles survival time of brain cancer patients in a small trial